Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Battaglin

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancerFilippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Role of <i>CD47</i> gene expression in colorectal cancer: a comprehensive molecular profiling studyHiroyuki Arai, Nishant Gandhi, Francesca Battaglin, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
The Oncologist|September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
International Journal of Cancer|December 31, 2024
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomesPooja Mittal, Francesca Battaglin, Yasmine Baca, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancerFilippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Role of <i>CD47</i> gene expression in colorectal cancer: a comprehensive molecular profiling studyHiroyuki Arai, Nishant Gandhi, Francesca Battaglin, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
The Oncologist|September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.
International Journal of Cancer|December 31, 2024
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomesPooja Mittal, Francesca Battaglin, Yasmine Baca, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
Pageof 9